FilingReader Intelligence
Zhifei Biological secures Helicobacter pylori vaccine patent
July 21, 2025 at 12:35 PM UTC•By FilingReader AI
Chongqing Zhifei Biological Products secured an invention patent for a recombinant Helicobacter pylori vaccine, strengthening its intellectual property portfolio in the vaccine development sector.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Announcement of Resolutions of the First Extraordinary General Meeting of Shareholders in 2025July 14, 2025 at 02:42 AM UTC
Beijing King & Wood (Chongqing) Law Firm's Legal Opinion on the First Extraordinary General Meeting of Shareholders of Chongqing Zhifei Biological Products Co., Ltd. in 2025July 14, 2025 at 02:42 AM UTC
News Alerts
Get instant email alerts when Chongqing Zhifei Biological Products publishes news
Free account required • Unsubscribe anytime